BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36377723)

  • 21. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
    Zhou W; Yue Y; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():748023. PubMed ID: 34790169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: Complete response of an anaplastic thyroid carcinoma patient with
    Gui L; Zhu Y; Li X; He X; Ma T; Cai Y; Liu S
    Front Immunol; 2023; 14():1178682. PubMed ID: 37122752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report.
    Luongo C; Porcelli T; Sessa F; De Stefano MA; Scavuzzo F; Damiano V; Klain M; Bellevicine C; Matano E; Troncone G; Schlumberger M; Salvatore D
    Curr Oncol; 2021 Dec; 28(6):5401-5407. PubMed ID: 34940089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer - Real-World Outcomes From UK Centres.
    Lorimer C; Cheng L; Chandler R; Garcez K; Gill V; Graham K; Grant W; Sardo Infirri S; Wadsley J; Wall L; Webber N; Wong KH; Newbold K
    Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e60-e66. PubMed ID: 36379836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
    Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
    Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma.
    Rao SN; Zafereo M; Dadu R; Busaidy NL; Hess K; Cote GJ; Williams MD; William WN; Sandulache V; Gross N; Gunn GB; Lu C; Ferrarotto R; Lai SY; Cabanillas ME
    Thyroid; 2017 May; 27(5):672-681. PubMed ID: 28068873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
    Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
    Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
    [No Abstract]   [Full Text] [Related]  

  • 28. Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature.
    Arıkan R; Telli TA; Demircan NC; Başoğlu T; Ercelep Ö; Atasoy BM; Özgüven S; Dane F; Yumuk PF
    Curr Probl Cancer; 2021 Apr; 45(2):100668. PubMed ID: 33127167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case report.
    Giannetta E; Isidori AM; Durante C; Di Gioia C; Longo F; Tombolini V; Bulzonetti N; Graziadio C; Pofi R; Gianfrilli D; Verrienti A; Carletti R; Filetti S; Lenzi A; Baroli A
    Medicine (Baltimore); 2017 Feb; 96(6):e5621. PubMed ID: 28178124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diallyl trisulphide, a H
    Zhang L; Xu S; Cheng X; Zheng J; Wang Y; Wu J; Wang X; Wu L; Yu H; Bao J
    Phytother Res; 2021 Jun; 35(6):3428-3443. PubMed ID: 33751676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete pathological response after chemo-radiation in anaplastic thyroid cancer: A report of two cases.
    Zanirato Rambaldi G; Monari F; Fiorentino M; Cammelli S; Repaci A; Cremonini N; Cavicchi O; Caliceti U; Farina E; Deodato F; Di Fabio F; Presutti L; Fanti S; Frezza GP; Morganti AG
    Acta Oncol; 2016; 55(4):530-2. PubMed ID: 26523660
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma.
    Geng M; Yang Y; Cao X; Dang L; Zhang T; Zhang L
    Biochem Biophys Res Commun; 2019 Dec; 520(3):544-550. PubMed ID: 31615655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive anaplastic thyroid carcinoma: report of a case and literature review.
    Dibelius G; Mehra S; Clain JB; Urken ML; Wenig BM
    Thyroid; 2014 Aug; 24(8):1319-24. PubMed ID: 24865498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer.
    Gunda V; Gigliotti B; Ashry T; Ndishabandi D; McCarthy M; Zhou Z; Amin S; Lee KE; Stork T; Wirth L; Freeman GJ; Alessandrini A; Parangi S
    Int J Cancer; 2019 May; 144(9):2266-2278. PubMed ID: 30515783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic thyroid carcinomas incidentally found on postoperative pathological examination.
    Yoshida A; Sugino K; Sugitani I; Miyauchi A
    World J Surg; 2014 Sep; 38(9):2311-6. PubMed ID: 24687351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012.
    Brignardello E; Palestini N; Felicetti F; Castiglione A; Piovesan A; Gallo M; Freddi M; Ricardi U; Gasparri G; Ciccone G; Arvat E; Boccuzzi G
    Thyroid; 2014 Nov; 24(11):1600-6. PubMed ID: 25110922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma.
    Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
    Park J; Jung HA; Shim JH; Park WY; Kim TH; Lee SH; Kim SW; Ahn MJ; Park K; Chung JH
    Eur J Endocrinol; 2021 May; 184(6):837-845. PubMed ID: 33852431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.